Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High-throughput Phenotyping of Lung Cancer Somatic Mutations
Alice H. Berger, Angela N. Brooks, Xiaoyun Wu, et al.
Cancer Cell (2016) Vol. 30, Iss. 2, pp. 214-228
Open Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian, Rajiv Narayan, Steven M. Corsello, et al.
Cell (2017) Vol. 171, Iss. 6, pp. 1437-1452.e17
Open Access | Times Cited: 2746
Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens
Atray Dixit, Oren Parnas, Biyu Li, et al.
Cell (2016) Vol. 167, Iss. 7, pp. 1853-1866.e17
Open Access | Times Cited: 1447
Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen, Darren A.E. Cross, Pasi A. Jänne
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 551-569
Open Access | Times Cited: 783
Genetic and transcriptional evolution alters cancer cell line drug response
Uri Ben‐David, Benjamin A. Siranosian, Gavin Ha, et al.
Nature (2018) Vol. 560, Iss. 7718, pp. 325-330
Open Access | Times Cited: 764
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras
Timothy C. Wang, Haiyan Yu, Nicholas W. Hughes, et al.
Cell (2017) Vol. 168, Iss. 5, pp. 890-903.e15
Open Access | Times Cited: 623
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Rodrigo Romero, Volkan I. Sayin, Shawn M. Davidson, et al.
Nature Medicine (2017) Vol. 23, Iss. 11, pp. 1362-1368
Open Access | Times Cited: 556
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
David Tamborero, Carlota Rubio-Pérez, Jordi Deu-Pons, et al.
Genome Medicine (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 469
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
Clotilde Wiel, Kristell Le Gal, Mohamed X. Ibrahim, et al.
Cell (2019) Vol. 178, Iss. 2, pp. 330-345.e22
Open Access | Times Cited: 460
Am I ready for CRISPR? A user's guide to genetic screens
John G. Doench
Nature Reviews Genetics (2017) Vol. 19, Iss. 2, pp. 67-80
Closed Access | Times Cited: 387
Accelerating Discovery of Functional Mutant Alleles in Cancer
Matthew T. Chang, Tripti Shrestha Bhattarai, Alison M. Schram, et al.
Cancer Discovery (2017) Vol. 8, Iss. 2, pp. 174-183
Open Access | Times Cited: 347
Image-based profiling for drug discovery: due for a machine-learning upgrade?
Srinivas Niranj Chandrasekaran, Hugo Ceulemans, Justin D. Boyd, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 2, pp. 145-159
Open Access | Times Cited: 326
CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine
Martin Kampmann
ACS Chemical Biology (2017) Vol. 13, Iss. 2, pp. 406-416
Open Access | Times Cited: 313
Systematic Functional Annotation of Somatic Mutations in Cancer
Patrick Kwok‐Shing Ng, Jun Li, Kang Jin Jeong, et al.
Cancer Cell (2018) Vol. 33, Iss. 3, pp. 450-462.e10
Open Access | Times Cited: 292
Current status and perspectives of patient-derived xenograft models in cancer research
Yunxin Lai, Xinru Wei, Shouheng Lin, et al.
Journal of Hematology & Oncology (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 263
Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer
Liron Bar‐Peled, Esther K. Kemper, Radu M. Suciu, et al.
Cell (2017) Vol. 171, Iss. 3, pp. 696-709.e23
Open Access | Times Cited: 252
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
Saioa López, Emilia L. Lim, Stuart Horswell, et al.
Nature Genetics (2020) Vol. 52, Iss. 3, pp. 283-293
Open Access | Times Cited: 221
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies
Utthara Nayar, Ofir Cohen, Christian Kapstad, et al.
Nature Genetics (2018) Vol. 51, Iss. 2, pp. 207-216
Open Access | Times Cited: 208
Phenotypic drug discovery: recent successes, lessons learned and new directions
Fabien Vincent, Arsenio Nueda, Jonathan Lee, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 899-914
Open Access | Times Cited: 201
A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer
Shinji Kohsaka, Masaaki Nagano, Toshihide Ueno, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 416
Open Access | Times Cited: 193
Precision Oncology: The Road Ahead
Daniela Senft, Mark D.M. Leiserson, Eytan Ruppin, et al.
Trends in Molecular Medicine (2017) Vol. 23, Iss. 10, pp. 874-898
Open Access | Times Cited: 176
The evolution of lung cancer and impact of subclonal selection in TRACERx
Alexander M. Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Nature (2023) Vol. 616, Iss. 7957, pp. 525-533
Open Access | Times Cited: 175
NRF2 Activation in Cancer: From DNA to Protein
Erica W. Cloer, Dennis Goldfarb, Travis P. Schrank, et al.
Cancer Research (2019) Vol. 79, Iss. 5, pp. 889-898
Open Access | Times Cited: 157
The evolution of non-small cell lung cancer metastases in TRACERx
Maise Al Bakir, Ariana Huebner, Carlos Martínez‐Ruiz, et al.
Nature (2023) Vol. 616, Iss. 7957, pp. 534-542
Open Access | Times Cited: 128
NRF2: KEAPing Tumors Protected
Ray Pillai, Makiko Hayashi, Anastasia‐Maria Zavitsanou, et al.
Cancer Discovery (2022) Vol. 12, Iss. 3, pp. 625-643
Open Access | Times Cited: 121
Cancer driver mutations: predictions and reality
Daria Ostroverkhova, Teresa M. Przytycka, Anna R. Panchenko
Trends in Molecular Medicine (2023) Vol. 29, Iss. 7, pp. 554-566
Open Access | Times Cited: 78
Page 1 - Next Page

Scroll to top